Response to recombinant human erythropoietin (r-hu epo) and l-carnitine combination in patients with anemia of end-stage renal disease

Nephron

Volumn 73, Issue 2, 1996, Pages 314-315

  Borati, Mediha ^a   Dalva, Izak ^a   Gônenç, Faruk ^a   Çetin, Selahattin ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CLINICAL ARTICLE; HEMODIALYSIS; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; LETTER; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TURKEY (REPUBLIC);

ANEMIA; CARNITINE; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN, RECOMBINANT; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 0029927105     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189060     Document Type: Article

References (13)

1. Esbach JW: The anemia of chronic renal failure: Pathophysiology and the effects of recombinant human erythropoietin. Kidney Ini 1989;45:134-148.
2. Lim SV. Degowin RL, Zavala D. Kirchner PT. Abels R. Perry P. Faugman S: Recombinant human erythropoietin treatment in pre-dialysis patient. Ann Intern Med 1989:2:108-110.
3. Welt LG, Sachs JR. McManus TS: An ion transport defect in erythrocytes from uremic patients. Trans Assoc Am Phvs 1964:77:169-171.
4. Lichtmann MA. Miller DR: Erythrocyte glycolysis. 2-3-diphosphoglyccrate and adenosine triphosphate concentration in uremic subjects: Relationship to extracellular phosphate concentration. J Lib Clin Med 1970;76:267-279.
5. Rose IA. Warms JVB: Control of glycolysis in human red blood cells. J. Biol Chem 1966:24: 4848-4851.
6. Yawata Y, llowe R. Jacob US: Abnormal red cell metabolism causing hemolysis in uremia: A defect potentiated by tap water hemodialysis. Ann Intern Med 1973;79:362-367.
7. Indeglia R. Bernstein S: Selective lipid loss following mechanical erythrocyte damage. Trans Am Soc Artif Intern Organs 1970:16:37-42.
8. Donalelli M. Terrizzi C. Zumano G. Russo V. Bucalo ML. Scarpinato A: CurrTher Res 1987: 41:1620-1624.
9. Arduino A. Gorbanov N. Arrigoni-Martelli E. Dottori S. Molajoni F. Russo F. Federici G: Effects of carnitine and its acetate and propionate esters on the molecular dynamics of human erythrocyte membrane. Biochim Biophys Acta 1993:1146:229-235.
10. Adamson JW. Eschbach JW. Finch CA: The kidney and erythropoiesis. Am J Med 1968:44: 725.
11. McMahon FG. Vargas R. Ryan M, Sain AK. Abels RL Perry B. Smith IL: Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injection in healthy volunteers. Blood 1990:76: 1718-1722.
12. Bohner T. Bergrem H. Eiklid F: Carnitine deficiency induced during intermittent hemodialysis for renal failure. Lancet 1978;i: 126-128.
13. Vacha GM. Giorgelli G. Siliprandi N, Corsi M: Favourable effects of ¿-carnitine treatment on hypertriglyceridemia in hemodialysis patients. Am J Clin Nutr 1983;38:532-540.